SMR Target to Patient (T2P) 2026

Monday, 20 Apr — Tuesday, 21 Apr '26

SMR Target to Patient 2026 (T2P26) conference which will be held at the Wellcome Genome Campus, Hinxton, near Cambridge, UK on April 20th and 21st, 2026. This is the third occurrence of this biannual meeting which will focus on ground-breaking advances during the following sessions following the drug discovery journey from Target to Patient:

  1. Machine Learning and Target identification
  2. Rewiring biology through induced proximity
  3. Impact of advances in analytical sciences
  4. Complex in vitro models
  5. Improving clinical trial outcomes

 

News

Upcoming Events